Covered recipient · General Payments record
ILEANA IRIZARRY MEDINA
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2022–2024
$894.42
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $368.35 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $159.28 | 6 |
| Lilly USA, LLC | $118.73 | 1 |
| Novo Nordisk AS | $48.81 | 2 |
| Merck Sharp & Dohme Corporation | $20.86 | 1 |
| Acerta Pharma LLC | $20.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.31 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969927 | CMS |
| ABBVIE INC. | $18.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969929 | CMS |
| ABBVIE INC. | $19.43 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969931 | CMS |
| ABBVIE INC. | $20.91 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969933 | CMS |
| ABBVIE INC. | $78.70 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969935 | CMS |
| ABBVIE INC. | $4.37 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103969937 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.67 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104500218 | CMS |
| Lilly USA, LLC | $118.73 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135026608 | CMS |
| Merck Sharp & Dohme LLC | $20.86 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141826874 | CMS |
| Novo Nordisk Inc | $23.81 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096563759 | CMS |
| Novo Nordisk Inc | $25.00 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096563215 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.